bpc 157 5mg vs 10mg BPC-157 5 mg vs. 10 mg: Dosage, Benefits BPC-157, TB-500 10mg Blend |

Description

Instead of a one-size-fits-all drug from big manufacturers, the pharmacist will mix or adjust ingredients in compounded medication to tailor to your specific needs

(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement

The honest summary: the three peptides individually sit somewhere between "intriguing preclinical compound with biological plausibility" and "early-stage research chemistry with insufficient human data." The blend is a research convenience, not an evidentiary upgrade